March 3, 2010

Cognigen Poster at American Pain Society Meeting

The work of Cognigen scientists Joel Owen, PhD, RPh*, and Inger Darling, PhD, was presented in a poster at the 29th Annual Scientific Meeting of the American Pain Society from May 6 to 9, 2010, in Baltimore. The poster, Single-Dose and Steady-State Pharmacokinetics of MoxDuo™, a Dual-Opioid Formulation Containing a Fixed-Ratio of Morphine and Oxycodone, was presented by QRxPharma and Lifetree Clinical Research.


February 24, 2010

Cognigen Poster at ASCPT

Cognigen scientists Jill Fiedler-Kelly, MS, Elizabeth Ludwig, PharmD, and Qiang Lu, PhD, presented a poster entitled Population Pharmacokinetics of Dexmedetomidine (DEX) During Long-Term Continuous Infusion in Critically Ill Patients, at the ASCPT meeting March 17 to 20, 2010, in Atlanta, Georgia.


February 19, 2010

PMI Pharma SIG Meets in Philadelphia

Cynthia Walawander, MA, PMP, Executive Vice President and Chief Operating Officer of Cognigen Corporation, has been named Marketing Chair of the Project Management Institute’s Pharmaceutical Special Interest Group (PharmaSIG).


November 3, 2009

Cognigen at 2009 AAPS Meeting

Cognigen scientists Beth Ludwig, Qiang Lu, Jill Fiedler-Kelly, and Ted Grasela attended the 2009 Annual Meeting of the American Association of Pharmaceutical Scientists (AAPS), November 8 to 12, 2009, in Los Angeles, California.


October 30, 2009

Cognigen & Janssen Poster at Psychiatric Congress

A poster describing the use of pharmacokinetic simulation to compare adherence patterns of patients with schizophrenia to two treatments with different PK profiles was presented at the U.S. Psychiatric and Mental Health Congress 2009 in Las Vegas, Nevada, November 2 to 5, 2009.


October 28, 2009

DIA / FDA / PhRMA Course

Ted Grasela led a breakout session called Model Development Using Accumulating Data, What About Model Validation? with Lei-Nie and Sue-Jane Wang of the FDA during the course Modeling and Simulation in Drug Development: Quantitative Approaches for Decision Making, which was jointly sponsored by the Drug Information Association, the Food and Drug Administration, and the Pharmaceutical Research and Manufacturers of America.


September 2, 2009

Drug Development and Regulatory Sciences Course

The University of California San Francisco School of Pharmacy held the American Course on Drug Development and Regulatory Sciences (ACDRS), Session 1, from Wednesday, September 30, to Friday, October 2, 2009, at the University of California, Washington Center, in Washington DC. Ted Grasela, President and CEO of Cognigen Corporation, was chairperson on Thursday and lectured on the topic: Model-Supported versus Model-Based Development - Implications for Leading and Governing R&D Programs.


August 5, 2009

Congress of International Drug Discovery

Ted Grasela was among a group of renowned speakers from around the world at the 7th Annual Congress of International Drug Discovery Science and Technology in Shanghai, China, from October 22 to 25, 2009.


July 22, 2009

Cognigen Completes Extensive Upgrade of Data Storage Infrastructure

Cognigen Corporation recently completed a significant upgrade of its data storage infrastructure. This strategic expansion of capabilities was required due to the increasing storage requirements and complexity of Cognigen’s pharmacometric modeling and simulation projects. The addition of Sun Microsystems ZFS technology is part of an ongoing expansion of capabilities designed to cement Cognigen’s position at the forefront of pharmacometric modeling and simulation.


July 15, 2009

Luann Phillips Teaches Math Workshop

Luann Phillips, director of PK/PD at Cognigen Corporation, presented Mathematical Modeling and the Medications You Take on June 30, 2009, at a summer mathematics institute for high school teachers sponsored by Rochester Institute of Technology’s School of Mathematical Sciences.


Page 8 of 9 pages. ‹ First  < 6 7 8 9 >